Cargando…

Phosphate, Microbiota and CKD

Phosphate is a key uremic toxin associated with adverse outcomes. As chronic kidney disease (CKD) progresses, the kidney capacity to excrete excess dietary phosphate decreases, triggering compensatory endocrine responses that drive CKD-mineral and bone disorder (CKD-MBD). Eventually, hyperphosphatem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Favero, Chiara, Carriazo, Sol, Cuarental, Leticia, Fernandez-Prado, Raul, Gomá-Garcés, Elena, Perez-Gomez, Maria Vanessa, Ortiz, Alberto, Fernandez-Fernandez, Beatriz, Sanchez-Niño, Maria Dolores
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070653/ https://www.ncbi.nlm.nih.gov/pubmed/33924419 http://dx.doi.org/10.3390/nu13041273

Ejemplares similares

Who killed Bruce Lee? The hyponatraemia hypothesis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKD
por: Carriazo, Sol, et al.
Publicado: (2023)

Chronodisruption: A Poorly Recognized Feature of CKD
por: Carriazo, Sol, et al.
Publicado: (2020)

MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy
por: Fernandez-Prado, Raul, et al.
Publicado: (2019)

Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved
por: Villalvazo, Priscila, et al.
Publicado: (2021)

The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality
por: Gonzalez-Martin, Guillermo, et al.
Publicado: (2020)

Blood pressure targets in CKD 2021: the never-ending guidelines debacle
por: Carriazo, Sol, et al.
Publicado: (2022)

Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022)

Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression
por: Castillo-Rodriguez, Esmeralda, et al.
Publicado: (2018)

Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2017)

Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
por: Martinez-Moreno, Julio M., et al.
Publicado: (2020)

SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific Therapies
por: Carriazo, Sol, et al.
Publicado: (2023)

Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials
por: Ortiz, Alberto, et al.
Publicado: (2019)

Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology
por: Carriazo, Sol, et al.
Publicado: (2020)

Solving the riddle of Aguascalientes nephropathy: nephron number, environmental toxins and family clustering
por: Villalvazo, Priscila, et al.
Publicado: (2022)

Dietary Care for ADPKD Patients: Current Status and Future Directions
por: Carriazo, Sol, et al.
Publicado: (2019)

Klotho, the elusive kidney-derived anti-ageing factor
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2019)

TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells
por: Valiño-Rivas, Lara, et al.
Publicado: (2018)

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes
por: Cuarental, Leticia, et al.
Publicado: (2020)

Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men
por: Fernandez-Prado, Raul, et al.
Publicado: (2018)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2017)

The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in Europe
por: Carriazo, Sol, et al.
Publicado: (2021)

European East–West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomes
por: Carriazo, Sol, et al.
Publicado: (2020)

Stopping kidney protection in the elderly following acute kidney injury: think mortality
por: Carriazo, Sol, et al.
Publicado: (2022)

Wasp stings and plasma exchange
por: Carriazo, Sol, et al.
Publicado: (2022)

Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2014)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Gain-of-function TLR7 and loss-of-function A20 gene variants identify a novel pathway for Mendelian lupus and lupus nephritis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study
por: Carriazo, Sol, et al.
Publicado: (2021)

Postbiotics and Kidney Disease
por: Favero, Chiara, et al.
Publicado: (2022)

Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2015)

Probiotics for kidney disease
por: Favero, Chiara, et al.
Publicado: (2022)

Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020)

More on the invisibility of chronic kidney disease… and counting
por: Carriazo, Sol, et al.
Publicado: (2021)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Modifiable Risk Factors for Increased Arterial Stiffness in Outpatient Nephrology
por: Elewa, Usama, et al.
Publicado: (2015)

Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ptmm91u5a865t4rcbfl2gsh2i7